rawfin.tv
Kalshi Launches Prediction Markets for Biopharma Clinical Trials
TechnologytechAI Generated

Kalshi Launches Prediction Markets for Biopharma Clinical Trials

By rawfin.tv Markets Desk||1 min read|AI-assisted · Methodology

Kalshi Inc. is expanding its prediction market offerings into the biopharmaceutical sector. The platform will allow users to wager on the outcomes of clinical trials and FDA regulatory decisions, introducing a new form of financial instrument.

Prediction MarketsBiotechnologyHealthcareFinancial InnovationRegulation

Related Articles

Amazon's AI Business Reaches $25 Billion Run Rate

Amazon's AI Business Reaches $25 Billion Run Rate

tech
OpenAI Nears $30 Billion Funding Round at $1.25 Trillion Valuation

OpenAI Nears $30 Billion Funding Round at $1.25 Trillion Valuation

tech
Anthropic S-1 Filing Reveals $80.7 Billion First-Half Loss Ahead of IPO

Anthropic S-1 Filing Reveals $80.7 Billion First-Half Loss Ahead of IPO

tech
Apple Partners with Meta to Run 816-Billion AI Model Locally

Apple Partners with Meta to Run 816-Billion AI Model Locally

tech